# FAST Fish Phase IIb Clinical Trial for the Treatment of Fish Allergy by Subcutaneous Immunotherapy

> **NCT02382718** · PHASE2 · COMPLETED · sponsor: **George Stavroulakis** · enrollment: 45 (actual)

## Conditions studied

- Food Allergy to Fish

## Interventions

- **BIOLOGICAL:** FAST fish mCyp c 1
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02382718
- **Lead sponsor:** George Stavroulakis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-02
- **Final completion:** 2017-04
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-06-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02382718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02382718, "FAST Fish Phase IIb Clinical Trial for the Treatment of Fish Allergy by Subcutaneous Immunotherapy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02382718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*